GINKGO BIOMEDICAL RES INST CO has a total of 13 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ANAMAR MEDICAL AB, CARTELA AB and MEDIRISTA BIOTECHNOLOGIES AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kamogawa Yumiko | 8 |
#2 | Ohkawa Jun | 5 |
#3 | Takemoto Naofumi | 4 |
#4 | Arai Ken-Ichi | 4 |
#5 | Miyatake Shoichiro | 4 |
#6 | Arai Naoko | 1 |
#7 | Ishida Koji | 1 |
#8 | Ken-Ichi Arai | 1 |
#9 | Shoichiro Miyatake | 1 |
#10 | Cho Minkwon | 1 |
Publication | Filing date | Title |
---|---|---|
WO2006054748A1 | Remedy for nephritis | |
WO2006013923A1 | Remedy for arthritis accompanied by autoimmune disease | |
WO2006008886A1 | Activity regulator for interferon producing cell | |
WO2004013325A1 | Method of detecting mouse interferon-producing cells | |
CA2483106A1 | Decoys for treating and/or preventing th2 cytokine-related allergic diseases, gata3 mutant proteins and, pharmaceutical compositions comprising the decoys and the proteins |